Feedback / Questions
Undisclosed KRAS selective inhibitor - Alterome Therap
ALTA-2618 - Alterome Therap
https://www.businesswire.com/news/home/20240403342221/en/Alterome-Therapeutics-Raises-132-Million-in-Series-B-Financing-Led-by-Goldman-Sachs-Alternatives
Apr 3, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next